Immunologic Criteria Are Poor Predictors of Virologic Outcome: Implications for HIV Treatment Monitoring in Resource-Limited Settings
Author(s) -
Holly Rawizza,
Beth Chaplin,
Seema Meloni,
Geoffrey Eisen,
T.K. Gundu Rao,
Jean-Louis Sankalé,
Abdoulaye Dieng-Sarr,
Oche Agbaji,
Obinna Onwujekwe,
Wadzani Gashau,
Reuben Nkado,
Ernest Ekong,
Prosper Okonkwo,
Robert L. Murphy,
P. J. Kanki
Publication year - 2011
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/cir729
Subject(s) - medicine , viral load , immunology , antiretroviral therapy , human immunodeficiency virus (hiv) , intensive care medicine
Viral load (VL) quantification is considered essential for determining antiretroviral treatment (ART) success in resource-rich countries. However, it is not widely available in resource-limited settings where the burden of human immunodeficiency virus infection is greatest. In the absence of VL monitoring, switches to second-line ART are based on World Health Organization (WHO) clinical or immunologic failure criteria.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom